• Millennium Group and Israel Englander report 5.7% stake in Protara (TARA) Stock Titan Tue, 07 Jul 2026 22:43:05 GMT
• Protara Therapeutics focuses on rare disease programs as development continues ad-hoc-news.de Tue, 07 Jul 2026 12:59:06 GMT
• Enterprise value to EBITDA forward of Protara Therapeutics, Inc. – NASDAQ:TARA TradingView Sun, 05 Jul 2026 16:47:48 GMT
• Protara Therapeutics, Inc. Actuals & Estimates (HAM:1KPA) TradingView Sun, 05 Jul 2026 10:42:03 GMT
• Protara Therapeutics (TARA) Holds Steady Near Support, Faces Resistance at $4.26 - Debt Free Companies dars.gov.et Sat, 04 Jul 2026 00:36:22 GMT
• Protara Therapeutics (TARA) CEO exercises options, sells 215,687 shares and makes 30,000-share gifts Stock Titan Wed, 01 Jul 2026 20:11:01 GMT
• enterprise value to ebitda forward of protara therapeutics, inc. – gettex:1kpa TradingView Wed, 01 Jul 2026 10:59:14 GMT
• does tara stock’s 15% after-hours slump signal a bargain after new bladder cancer data? Stocktwits Tue, 30 Jun 2026 16:13:04 GMT
• form 144 protara therapeutics for: 29 june by investing.com Investing.com South Africa Tue, 30 Jun 2026 00:11:44 GMT
• Form 144 PROTARA THERAPEUTICS For: 29 June By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 22:28:40 GMT
• Protara Therapeutics (TARA) CMO Leonardo Nicacio resigns, duties reassigned Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• does tara stock’s 15% after-hours slump signal a bargain after new bladder cancer data? Stocktwits Sun, 28 Jun 2026 17:07:08 GMT
• protara therapeutics, inc. actuals & estimates (mun:1kpa) TradingView Fri, 26 Jun 2026 08:58:49 GMT
• protara therapeutics, inc. actuals & estimates (swb:1kpa) TradingView Fri, 26 Jun 2026 05:18:15 GMT
• enterprise value to revenue forward of protara therapeutics, inc. – nasdaq:tara TradingView Thu, 25 Jun 2026 23:10:56 GMT
• protara therapeutics, inc. actuals & estimates (fwb:1kpa) TradingView Thu, 25 Jun 2026 22:38:17 GMT
• price to earnings forward of protara therapeutics, inc. – nasdaq:tara TradingView Thu, 25 Jun 2026 14:31:30 GMT
• protara therapeutics inc (tara) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• does tara stock’s 15% after-hours slump signal a bargain after new bladder cancer data? Stocktwits Tue, 23 Jun 2026 05:45:08 GMT
• lifesci capital maintains protara therapeutics(tara.us) with buy rating, maintains target price $26 富途牛牛 Mon, 22 Jun 2026 21:41:53 GMT
• protara therapeutics inc (tara) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Protara Therapeutics Inc (TARA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 12:54:59 GMT
• protara therapeutics inc (tara) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 12:52:31 GMT
• protara therapeutics inc (tara) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 12:38:59 GMT
• protara therapeutics inc (tara) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 18:57:57 GMT
• protara therapeutics inc (tara) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 18:57:26 GMT
• protara therapeutics inc (tara) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 18:57:15 GMT
• Protara Therapeutics Inc (TARA) Valuation: PE, PB & Fair Value Analysis TradingKey Wed, 17 Jun 2026 18:47:58 GMT
• protara therapeutics inc (tara) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:23:13 GMT
• Director at Protara Therapeutics (NASDAQ: TARA) awarded 31,000 stock options at $3.94 Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Protara (TARA) director granted 31,000 stock options at $3.94 strike Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Protara Therapeutics (TARA) awards director 31,000 stock options at $3.94 Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Cynthia Smith granted 31,000 stock options at Protara Therapeutics (TARA) Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Protara Therapeutics (TARA) director awarded 31,000 stock options at $3.94 strike Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Protara (TARA) director receives 31,000 stock options at $3.94 strike Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Jane Huang awarded 31,000 Protara (TARA) stock options as director grant Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• protara (tara) director awarded 31,000 options at $3.94 strike Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• protara therapeutics inc (tara) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• protara therapeutics inc (tara) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• protara therapeutics inc (tara) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• protara therapeutics inc (tara) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• protara therapeutics stockholders approve governance and share increases TipRanks Mon, 15 Jun 2026 21:14:21 GMT
• Protara Therapeutics Inc. (TARA) Gains 1.41% as Stock Nears Key Resistance - Protective Put dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• protara therapeutics (tara) investors approve share increase and pay items Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• does tara stock’s 15% after-hours slump signal a bargain after new bladder cancer data? Stocktwits Sun, 14 Jun 2026 07:35:54 GMT
• tara q1 2026 earnings: narrower-than-expected loss drives positive sentiment - earnings forecast report newsline.com Sat, 13 Jun 2026 15:37:44 GMT
• protara therapeutics (tara) q1 2026 earnings: narrower-than-expected loss drives stock gain - earnings power value newsline.com Sat, 13 Jun 2026 13:33:08 GMT
• William Conkling appointed to IDT board as Irwin Katsof resigns TradingView Thu, 11 Jun 2026 07:00:00 GMT
• protara therapeutics (tara) dips 3.8% as stock nears key support level - narrow range breakout dars.gov.et Thu, 11 Jun 2026 07:00:00 GMT
• Protara Therapeutics Q1 2026 Earnings: EPS Beat Driven by Expense Management, Stock Slips - Estimate Dispersion dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• tara q1 2026 earnings: narrower-than-expected loss of -$0.31 per share as clinical pipeline advances dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• does tara stock’s 15% after-hours slump signal a bargain after new bladder cancer data? Stocktwits Fri, 05 Jun 2026 19:20:43 GMT
• protara therapeutics q1 2026 earnings: narrower-than-expected loss fails to lift sentiment - product revenue analysis newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• protara therapeutics (nasdaq: tara) cco has 6,008 rsu shares withheld for taxes Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Wed, 03 Jun 2026 04:54:45 GMT
• protara therapeutics inc at td cowen healthcare conference transcript GuruFocus Tue, 02 Jun 2026 07:38:18 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Sun, 31 May 2026 01:49:16 GMT
• protara therapeutics (tara) dips 2% as stock hovers near support - charm flow thelegaladvocate.com Sat, 30 May 2026 01:48:43 GMT
• TARA Q1 2026 Earnings: Narrower-than-Expected Loss as Pipeline Advances - Tax Rate Impact dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• protara therapeutics (tara) dips 2% as stock hovers near support - volatility smile newsline.com Fri, 29 May 2026 07:00:00 GMT
• Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering TradingView Thu, 28 May 2026 07:00:00 GMT
• protara therapeutics (nasdaq: tara) secures $100m atm sales agreement with td cowen Stock Titan Thu, 28 May 2026 07:00:00 GMT
• protara therapeutics (tara) q1 2026 earnings: narrower-than-expected loss as cash management supports bottom line - management gui... newsline.com Thu, 28 May 2026 07:00:00 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Wed, 27 May 2026 14:27:09 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Tue, 26 May 2026 12:04:34 GMT
• TARA: TARA-002 shows strong efficacy and regulatory momentum in LM and NMIBC, with key H2 catalysts TradingView Tue, 26 May 2026 07:00:00 GMT
• protara therapeutics q1 2026 earnings: eps beat despite no revenue; stock declines - tangible book value newsline.com Tue, 26 May 2026 07:00:00 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Mon, 25 May 2026 10:17:29 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Sat, 23 May 2026 16:03:37 GMT
• protara therapeutics q1 2026 earnings: eps beats estimates amid continued pipeline progress - estimate accuracy newsline.com Sat, 23 May 2026 07:00:00 GMT
• piper sandler initiates coverage of protara therapeutics (tara) with overweight recommendation MSN Sat, 23 May 2026 00:32:33 GMT
• analysts’ top healthcare picks: protara therapeutics (tara), elevance health (elv) The Globe and Mail Thu, 21 May 2026 10:32:00 GMT
• piper sandler maintains protara therapeutics(tara.us) with buy rating, announces target price $24 Moomoo Thu, 21 May 2026 09:51:17 GMT
• analysts offer insights on healthcare companies: pepgen inc. (pepg) and protara therapeutics (tara) The Globe and Mail Thu, 21 May 2026 07:00:00 GMT
• protara therapeutics inc stock (us87612e1064): analyst optimism contrasts with volatile share price AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• protara therapeutics (tara) stock: jumps +4.10%, approaching $5.21 2026-05-21 - liquidity order flow newsline.com Thu, 21 May 2026 07:00:00 GMT
• protara therapeutics (tara) receives a buy from oppenheimer The Globe and Mail Thu, 21 May 2026 07:00:00 GMT
• a quick look at today's ratings for protara therapeutics(tara.us), with a forecast between $24 to $28 Moomoo Thu, 21 May 2026 07:00:00 GMT
• a quick look at today's ratings for protara therapeutics(tara.us), with a forecast between $25 to $27 Moomoo Wed, 20 May 2026 17:52:57 GMT
• tara maintained by oppenheimer -- price target raised to $28.00 GuruFocus Wed, 20 May 2026 17:03:15 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Wed, 20 May 2026 15:59:19 GMT
• protara therapeutics price target raised to $28 from $25 at oppenheimer TipRanks Wed, 20 May 2026 14:52:45 GMT
• protara therapeutics inc lymphatic malformations kol webinar transcript GuruFocus Wed, 20 May 2026 12:52:36 GMT
• peaker reiterates buy on tara-002 after strong starborn-2 data, sets $25 price target on accelerated approval potential TipRanks Wed, 20 May 2026 12:24:23 GMT
• Cantor Fitzgerald reiterates Protara Therapeutics stock rating Investing.com Wed, 20 May 2026 07:00:00 GMT
• Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• H.C. Wainwright reiterates Protara stock rating citing LM data Investing.com Wed, 20 May 2026 07:00:00 GMT
• protara therapeutics, inc. (tara) discusses interim safety and durability data from starborn-1 trial of tara-002 in lymphatic malf... Seeking Alpha Wed, 20 May 2026 07:00:00 GMT
• protara therapeutics to present at td cowen oncology summit on may 20, 2026, following asco and eha meetings geneonline.com Wed, 20 May 2026 07:00:00 GMT
• oppenheimer adjusts protara therapeutics pt to $28 from $25, maintains outperform rating Moomoo Wed, 20 May 2026 07:00:00 GMT
• tara: tara-002 delivers strong, durable efficacy and safety for lymphatic malformations, targeting fda approval TradingView Tue, 19 May 2026 23:14:19 GMT
• protara therapeutics reports 55% complete response rate in bladder cancer study MSN Tue, 19 May 2026 11:10:28 GMT
• j.p. morgan maintains protara therapeutics(tara.us) with buy rating, maintains target price $26 Moomoo Tue, 19 May 2026 07:00:00 GMT
• protara therapeutics to host investor webinar on tara-002 for lymphatic malformations on may 19, 2026 geneonline.com Tue, 19 May 2026 07:00:00 GMT
• protara therapeutics (tara) stock analysis: falls -0.65%, watching $4.34 2026-05-19 - intraday profile thelegaladvocate.com Tue, 19 May 2026 07:00:00 GMT
• protara’s cell therapy shows treatment durability in mid-stage nmibc study MSN Tue, 19 May 2026 03:09:43 GMT
• Protara’s cell therapy shows treatment durability in mid-stage NMIBC study Clinical Trials Arena Mon, 18 May 2026 07:00:00 GMT
• Protara Therapeutics to Host Virtual Webinar on Lymphatic Malformations and TARA-002 Clinical Program Quiver Quantitative Mon, 18 May 2026 07:00:00 GMT
• protara therapeutics to host virtual investor webinar to discuss tara-002 for lymphatic malformations on tuesday, may 19, 2026 GlobeNewswire Mon, 18 May 2026 07:00:00 GMT
• inside protara’s may 19 webinar on lymphatic malformations and tara-002 Stock Titan Mon, 18 May 2026 07:00:00 GMT
• protara therapeutics inc stock (us87612e1064): bladder cancer data put small-cap biotech in focus AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• protara therapeutics reports 55% complete response rate in bladder cancer study MSN Sun, 17 May 2026 02:57:28 GMT
• lifesci capital maintains protara therapeutics(tara.us) with buy rating, maintains target price $26 富途牛牛 Sat, 16 May 2026 07:00:00 GMT
• protara therapeutics (tara) unveils promising phase 2 trial resu GuruFocus Fri, 15 May 2026 18:05:56 GMT
• protara announces updated 12-month data from cohort a of advanced-2 trial TipRanks Fri, 15 May 2026 13:49:23 GMT
• Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Coho... Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Protara reports positive 12-month data for bladder cancer drug grafa.com Fri, 15 May 2026 07:00:00 GMT
• Protara's TARA-002 Shows Durable Bladder Cancer Response at 12 Months BriefGlance Fri, 15 May 2026 07:00:00 GMT
• bladder cancer drug tara-002 shows 55% complete response at 12 months Stock Titan Fri, 15 May 2026 07:00:00 GMT
• h.c. wainwright maintains protara therapeutics(tara.us) with buy rating, maintains target price $27 富途牛牛 Fri, 15 May 2026 07:00:00 GMT
• janus henderson (tara) disclosed 5.21m-share, 9.6% stake in protara Stock Titan Fri, 15 May 2026 07:00:00 GMT
• protara reports 12-month data for bladder cancer therapy Investing.com Fri, 15 May 2026 07:00:00 GMT
• oppenheimer keeps their buy rating on protara therapeutics (tara) The Globe and Mail Fri, 15 May 2026 07:00:00 GMT
• protara therapeutics reports 55% complete response rate in bladder cancer study Benzinga Fri, 15 May 2026 07:00:00 GMT
• protara therapeutics 1q research and development expenses $13.6m >tara Moomoo Thu, 14 May 2026 21:12:13 GMT
• protara's tara-002 shows durable bladder cancer response at 12 months BriefGlance Thu, 14 May 2026 15:48:58 GMT
• a quick look at today's ratings for protara therapeutics(tara.us), with a forecast between $21 to $30 Moomoo Thu, 14 May 2026 13:00:00 GMT
• Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Immunic (IMUX) and Protara Therapeutics (TARA) The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• Protara Therapeutics stock (US87612E1064): Q1 earnings beat estimates with narrower loss ad-hoc-news.de Thu, 14 May 2026 07:00:00 GMT
• tara maintained by jp morgan -- price target lowered to $26.00 GuruFocus Thu, 14 May 2026 07:00:00 GMT
• protara therapeutics, inc. q1 2026 financial report: key updates, forward-looking statements, and financial highlights Minichart Thu, 14 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: femasys (femy) and protara therapeutics (tara) The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• protara therapeutics 1q research and development expenses $13.6m >tara Moomoo Wed, 13 May 2026 23:20:40 GMT
• protara therapeutics, inc. q1 2026 financial report: key updates, forward-looking statements, and financial highlights Minichart Wed, 13 May 2026 16:55:00 GMT
• protara therapeutics (tara) prepares for bla submission followin GuruFocus Wed, 13 May 2026 16:47:04 GMT
• Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• Protara Therapeutics, Inc. Q1 2026: Net income $(17.8M), EPS $(0.31) — 10-Q Summary TradingView Wed, 13 May 2026 07:00:00 GMT
• biotech protara funds tara-002 programs into 2028, targets 2027 biologics filing Stock Titan Wed, 13 May 2026 07:00:00 GMT
• protara therapeutics reports q1 2026 results, advances tara-002 for lymphatic malformations and nmibc with bla planned for 2027 Minichart Wed, 13 May 2026 07:00:00 GMT
• protara therapeutics reports q1 2026 net loss $17.8m; cash and investments $177.4m TradingView Wed, 13 May 2026 07:00:00 GMT
• protara therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 13 May 2026 07:00:00 GMT
• protara therapeutics (nasdaq: tara) posts q1 loss and details tara-002 plans Stock Titan Wed, 13 May 2026 07:00:00 GMT
• protara therapeutics (nasdaq: tara) files $300m shelf registration for future offerings Stock Titan Wed, 13 May 2026 07:00:00 GMT
Protara Therapeutics, Inc(NASDAQ:TARA) 
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformation...
Share this website to your friends